VNRX Wutah bathi saben saham ing taun lumaku volition.com

Simbol resmi perusahaan volition.com (VNRX)

VolitionRx Limited leads in epigenetic oncology screening by investing in the unique Nucleosomics technology. Year-over-year changes in EPS reflect capital dynamics, where the value of 55.60 expresses the metric level. AI-powered robotic systems accelerate blood analysis, providing the company with a competitive advantage due to the platform's versatility in both human and veterinary medicine.

Wutah bathi saben saham ing taun lumaku: VolitionRx Limited (VNRX) kanggo 04.07.2022 - 15.11.2026

Rincian analitis lan laporan data perusahaan VolitionRx Limited (VNRX)

- nilai pasar lan prakiraan target analis:
Rega saham VolitionRx Ltd|VNRX - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar VolitionRx Ltd.|VNRX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- indikator kapitalisasi buku:
Nilai Aset Bersih saben Saham VolitionRx|VNRX - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku volition.com|VNRX - Total Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Koefisien Total Utang marang Modal VolitionRx Limited|VNRX - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal VolitionRx Limited|VNRX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku VolitionRx Limited|VNRX - Utang jangka dawa perusahaan|Utang jangka cendhak VolitionRx|Likuiditas cepet volition.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
VNRX - Bathi resik|Prakiraan bathi perusahaan VolitionRx Limited|VNRX - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep VolitionRx Ltd.|VNRX - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan VolitionRx Limited|VNRX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan VolitionRx|VNRX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan volition.com|VNRX - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep VolitionRx Limited
- data pendapatan lan penerimaan dodolan:
VNRX - Dodolan perusahaan|Prakiraan pendapatan perusahaan VolitionRx Limited|VNRX - Kapitalisasi marang pendapatan|Rega forward marang dodolan VolitionRx Limited
Ringkesan analisis perusahaan:volition.com, VNRX
Produk seri VolitionRx Ltd

Investors use this indicator as a leading signal for future stock returns. The metric captures the percentage deviation of current earnings per share from the same value last year. Current annual EPS progress has reached 55.60. This price action reflects the monetization efficiency of the Nu.Q platform. The strong pricing power of VolitionRx Limited (VNRX) in the early cancer diagnostics segment converts directly into the growth of this fundamental indicator.

Pesaing utama

CAI (Caris Life Sciences, Inc.) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku guardanthealth.com|Wutah bathi saben saham ing taun lumaku VCYT|Wutah bathi resik saben saham ing taun iki CELC (Celcuity Therapeutics)|GRAL - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Myriad MYGN|Prakiraan wutah bathi resik saben saham ing taun iki Castle Biosciences Corp (CSTL)|BNR - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki biodesix.com BDSX|Precipio Inc. (PRPO) - Wutah bathi saben saham ing taun lumaku|CHEK - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku mainzbiomed.com|Wutah bathi saben saham ing taun iki OCX (OncoCyte Corp.)